Cargando…
Discovery and evaluation of triple inhibitors of VEGFR-2, TIE-2 and EphB4 as anti-angiogenic and anti-cancer agents
Receptor tyrosine kinases (RTKs), especially VEGFR-2, TIE-2, and EphB4, play a crucial role in both angiogenesis and tumorigenesis. Moreover, complexity and heterogeneity of angiogenesis make it difficult to treat such pathological traits with single-target agents. Herein, we developed two classes o...
Autores principales: | Zhang, Lin, Shan, Yuanyuan, Ji, Xingyue, Zhu, Mengyuan, Li, Chuansheng, Sun, Ying, Si, Ru, Pan, Xiaoyan, Wang, Jinfeng, Ma, Weina, Dai, Bingling, Wang, Binghe, Zhang, Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5739597/ https://www.ncbi.nlm.nih.gov/pubmed/29285210 http://dx.doi.org/10.18632/oncotarget.20065 |
Ejemplares similares
-
Low Expression of EphB2, EphB3, and EphB4 in Bladder Cancer: Novel Potential Indicators of Muscular Invasion
por: Lee, Tae Ho, et al.
Publicado: (2021) -
The Roles of EphB2 in Cancer
por: Liu, Wei, et al.
Publicado: (2022) -
Inhibition of choroidal neovascularization by anti-EphB4 monoclonal antibody
por: SU, DONGFENG, et al.
Publicado: (2013) -
The Differential Expression of EphB2 and EphB4 Receptor Kinases in Normal Bladder and in Transitional Cell Carcinoma of the Bladder
por: Li, Xiuqing, et al.
Publicado: (2014) -
Reelin induces EphB activation
por: Bouché, Elisabeth, et al.
Publicado: (2013)